These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2318 related articles for article (PubMed ID: 31178151)

  • 1. Nasopharyngeal carcinoma.
    Chen YP; Chan ATC; Le QT; Blanchard P; Sun Y; Ma J
    Lancet; 2019 Jul; 394(10192):64-80. PubMed ID: 31178151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma.
    Cavalieri S; Licitra L
    Cancer; 2020 Aug; 126(16):3624-3626. PubMed ID: 32497251
    [No Abstract]   [Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma.
    Chua MLK; Wee JTS; Hui EP; Chan ATC
    Lancet; 2016 Mar; 387(10022):1012-1024. PubMed ID: 26321262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus as a paradigm in nasopharyngeal cancer: from lab to clinic.
    Raghupathy R; Hui EP; Chan AT
    Am Soc Clin Oncol Educ Book; 2014; ():149-53. PubMed ID: 24857071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging treatment options for nasopharyngeal carcinoma.
    Zhang L; Chen QY; Liu H; Tang LQ; Mai HQ
    Drug Des Devel Ther; 2013; 7():37-52. PubMed ID: 23403548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
    Sun XS; Liu LT; Liu SL; Guo SS; Wen YF; Xie HJ; Tang QN; Liang YJ; Li XY; Yan JJ; Ma J; Chen QY; Tang LQ; Mai HQ
    BMC Cancer; 2019 Jan; 19(1):92. PubMed ID: 30665378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma.
    Renaud S; Lefebvre A; Mordon S; Moralès O; Delhem N
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Nasopharyngeal Carcinoma: Is Adjuvant Therapy Needed?
    Lee VH; Lam KO; Chang AT; Lam TC; Chiang CL; So TH; Choi CW; Lee AW
    J Oncol Pract; 2018 Oct; 14(10):594-602. PubMed ID: 30312564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study.
    Guo SS; Tang LQ; Chen QY; Zhang L; Liu LT; Guo L; Mo HY; Luo DH; Huang PY; Xiang YQ; Sun R; Chen MY; Wang L; Lv X; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Oncotarget; 2016 May; 7(20):29739-48. PubMed ID: 27105538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
    Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM
    Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitous Distribution of Epstein-Barr Virus and the Highly Uneven Distribution of Nasopharyngeal Carcinoma.
    Wang CQ; He J
    Chin Med J (Engl); 2016 Oct; 129(20):2506-2507. PubMed ID: 27748347
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.
    Coghill AE; Wang CP; Verkuijilen SAWM; Yu KJ; Hsu WL; Middeldorp JM; Hildesheim A
    J Med Virol; 2018 Jan; 90(1):191-195. PubMed ID: 28833336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?
    Juarez-Vignon Whaley JJ; Afkhami M; Sampath S; Amini A; Bell D; Villaflor VM
    Curr Treat Options Oncol; 2023 Jul; 24(7):845-866. PubMed ID: 37145382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment.
    Adham M; Greijer AE; Verkuijlen SA; Juwana H; Fleig S; Rachmadi L; Malik O; Kurniawan AN; Roezin A; Gondhowiardjo S; Atmakusumah D; Stevens SJ; Hermani B; Tan IB; Middeldorp JM
    Clin Cancer Res; 2013 Apr; 19(8):2175-86. PubMed ID: 23493345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Perspectives on Nasopharyngeal Carcinoma.
    Lee HM; Okuda KS; González FE; Patel V
    Adv Exp Med Biol; 2019; 1164():11-34. PubMed ID: 31576537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic approaches in nasopharyngeal carcinoma.
    Chow JC; Ngan RK; Cheung KM; Cho WC
    Expert Opin Biol Ther; 2019 Nov; 19(11):1165-1172. PubMed ID: 31361154
    [No Abstract]   [Full Text] [Related]  

  • 19. Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer.
    Loong HH; Ma BB; Chan AT
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1267-78, x. PubMed ID: 19010273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal management of nasopharyngeal carcinoma.
    Faivre S; Janot F; Armand JP
    Curr Opin Oncol; 2004 May; 16(3):231-5. PubMed ID: 15069318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 116.